Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-01-24 09:44 Tx date 2024-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
375,000 | |
Filed 2024-01-04 12:54 Tx date 2024-01-02 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units (equity settled)
46 - Compensation for services
|
$12,499
+208,333 vol $0.06 each |
475,427 | |
Filed 2023-08-18 11:17 Tx date 2023-08-16 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units (equity settled)
46 - Compensation for services
|
$24,999
+267,094 vol $0.0936 each |
267,094 | |
Filed 2023-08-18 11:11 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units (equity settled)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-07-06 15:11 Tx date 2023-07-04 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+30,300 vol |
80,200 | |
Filed 2023-06-20 13:09 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,200
+40,000 vol $6.03 each |
364,100 | |
Filed 2022-12-28 14:13 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$788.00
+400 vol $1.97 each |
29,802 | |
Filed 2022-12-28 14:12 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,300
+1,211 vol $1.90 each |
29,402 | |
Filed 2022-12-28 14:12 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$740.28
+372 vol $1.99 each |
28,191 | |
Filed 2022-12-28 14:11 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,027
+519 vol $1.98 each |
27,819 | |
Filed 2022-12-28 14:05 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$788.00
+400 vol $1.97 each |
||
Filed 2022-12-28 14:04 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,300
+1,211 vol $1.90 each |
||
Filed 2022-12-28 14:04 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$740.28
+372 vol $1.99 each |
||
Filed 2022-12-28 14:03 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,027
+519 vol $1.98 each |
||
Filed 2022-12-28 14:02 Tx date 2022-12-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$56.00
+28 vol $2.00 each |
27,300 | |
Filed 2022-08-31 12:48 Tx date 2022-08-31 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,900
+100,000 vol $0.109 each |
350,500 | |
Filed 2022-08-23 15:45 Tx date 2022-08-02 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,200 vol |
19,200 | |
Filed 2022-08-23 15:41 Tx date 2016-11-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-23 11:49 Tx date 2022-08-02 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$853,084
+101,800 vol $8.38 each |
324,100 | |
Filed 2022-07-15 15:08 Tx date 2022-07-14 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$74,998
+27,272 vol $2.75 each |
27,272 | |
Filed 2022-07-06 12:33 Tx date 2022-07-06 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-2,152 vol |
0 | |
Filed 2022-07-05 16:35 Tx date 2022-06-30 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+120,192 vol |
263,670 | |
Filed 2022-02-18 18:00 Tx date 2022-02-17 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+23,100 vol |
49,900 | |
Filed 2022-02-18 17:59 Tx date 2022-02-17 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
250,000 | |
Filed 2022-01-13 17:06 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$188,881
+22,300 vol $8.47 each |
222,300 | |
Filed 2021-07-21 18:52 Tx date 2021-07-19 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+26,800 vol |
26,800 | |
Filed 2021-07-21 18:51 Tx date 2020-11-06 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-04 09:28 Tx date 2021-06-30 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+143,478 vol |
143,478 | |
Filed 2021-07-04 09:24 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights DSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-04 09:21 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights DSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-01 17:34 Tx date 2021-06-30 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+375,000 vol |
575,000 | |
Filed 2021-05-27 13:37 Tx date 2021-05-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72.50
+500 vol $0.145 each |
250,500 | |
Filed 2021-04-26 11:01 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,487
+5,715 vol $3.06 each |
149,636 | |
Filed 2021-04-26 11:00 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,672
+1,208 vol $3.04 each |
143,921 | |
Filed 2021-04-26 11:00 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,420
+2,000 vol $3.21 each |
142,713 | |
Filed 2021-04-26 10:58 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$117,600
+36,750 vol $3.20 each |
140,713 | |
Filed 2021-04-26 10:58 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,772
+2,750 vol $3.19 each |
103,963 | |
Filed 2021-04-26 10:57 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,856
+3,200 vol $3.08 each |
101,213 | |
Filed 2021-04-26 10:57 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,105
+5,500 vol $3.11 each |
98,013 | |
Filed 2021-04-26 10:56 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,005
+3,585 vol $3.07 each |
92,513 | |
Filed 2021-04-26 10:55 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,334
+425 vol $3.14 each |
88,928 | |
Filed 2021-04-26 10:55 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,050
+5,500 vol $3.10 each |
88,503 | |
Filed 2021-04-26 10:54 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$626.00
+200 vol $3.13 each |
83,003 | |
Filed 2021-04-26 10:54 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,243
+3,850 vol $3.18 each |
82,803 | |
Filed 2021-04-26 10:53 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$17,472
+5,600 vol $3.12 each |
78,953 | |
Filed 2021-04-26 10:53 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,195
+392 vol $3.05 each |
73,353 | |
Filed 2021-04-26 10:52 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,944
+1,600 vol $3.09 each |
72,961 | |
Filed 2021-04-26 10:51 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,133
+675 vol $3.16 each |
71,361 | |
Filed 2021-04-26 10:50 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,144
+3,200 vol $3.17 each |
70,686 | |
Filed 2021-04-26 10:50 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$315.00
+100 vol $3.15 each |
67,486 | |
Filed 2021-04-26 10:49 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,562
+500 vol $3.13 each |
67,386 | |
Filed 2021-04-26 10:48 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$259,835
+82,750 vol $3.14 each |
||
Filed 2021-04-23 18:49 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$259,835
+82,750 vol $3.14 each |
||
Filed 2021-04-23 18:46 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$259,835
+82,750 vol $3.14 each |
||
Filed 2021-04-23 18:49 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$259,835
+82,750 vol $3.14 each |
149,636 | |
Filed 2021-04-23 18:46 Tx date 2021-04-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$259,835
+82,750 vol $3.14 each |
||
Filed 2021-03-30 14:33 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$848,000
+200,000 vol $4.24 each |
200,000 | |
Filed 2021-03-30 14:32 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,500 vol |
0 | |
Filed 2021-02-26 17:03 Tx date 2021-02-25 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+100,000 vol $0.12 each |
250,000 | |
Filed 2021-01-27 10:28 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2021-01-27 10:24 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
||
Filed 2021-01-26 19:08 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
||
Filed 2021-01-26 19:14 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
Filed 2021-01-26 19:08 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
350,000 | |
Filed 2021-01-26 19:06 Tx date 2021-01-21 |
$BRAU
BIG RIDGE GOLD CORP. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-30 20:09 Tx date 2020-11-30 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,300
+15,000 vol $1.62 each |
15,000 | |
Filed 2020-11-30 20:08 Tx date 2020-11-06 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-10 11:48 Tx date 2020-11-09 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$282,000
+200,000 vol $1.41 each |
200,000 | |
Filed 2020-11-10 11:47 Tx date 2020-11-06 |
$WRN
Western Copper and Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-14 15:47 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-20,052,392 vol |
66,886 | |
Filed 2020-01-03 15:44 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-20,052,214 vol |
||
Filed 2020-01-03 15:44 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-20,052,214 vol |
67,064 | |
Filed 2020-01-03 15:44 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-643,448 vol |
2,152 | |
Filed 2020-01-03 15:42 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-747,500 vol |
2,500 | |
Filed 2020-01-03 14:19 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-632,000 vol |
750,000 | |
Filed 2019-11-14 16:30 Tx date 2019-11-14 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-2,806,041 vol |
645,600 | |
Filed 2019-10-16 11:53 Tx date 2019-10-15 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$149,999
+2,142,857 vol $0.07 each |
20,119,278 | |
Filed 2019-09-11 11:48 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$450,000
+6,428,572 vol $0.07 each |
17,976,421 | |
Filed 2019-09-11 11:48 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,000
+100,000 vol $0.07 each |
11,547,849 | |
Filed 2019-06-11 21:28 Tx date 2019-06-05 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
$124,996
+9,850 vol $12.69 each |
26,603 | |
Filed 2019-05-21 15:09 Tx date 2019-05-14 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,303 vol |
5,303 | |
Filed 2019-05-21 15:08 Tx date 2018-12-13 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-19 Tx date 2019-03-18 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+4,927 vol |
16,753 | |
Filed 2019-03-13 Tx date 2019-03-13 |
$Z
Zinc One Resources Inc. (formerly Rockridge Capital Corp.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+1,000,000 vol $0.10 each |
2,011,364 | |
Filed 2019-03-11 Tx date 2018-12-13 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-11 Tx date 2019-03-11 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,714
+2,500 vol $9.49 each |
2,500 | |
Filed 2018-12-19 Tx date 2018-12-17 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
10 - Acquisition or disposition in the public market
|
+11,826 vol |
||
Filed 2018-12-19 Tx date 2018-12-17 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
10 - Acquisition or disposition in the public market
|
+11,826 vol |
||
Filed 2018-12-18 Tx date 2018-12-17 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+11,826 vol |
23,652 | |
Filed 2018-12-18 Tx date 2018-12-17 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
10 - Acquisition or disposition in the public market
|
+11,826 vol |
11,826 | |
Filed 2018-12-18 Tx date 2018-12-13 |
$DGC
Detour Gold Corporation |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$64,560
+645,600 vol $0.10 each |
3,451,641 | |
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$90,384
+645,600 vol $0.14 each |
11,447,849 | |
Filed 2018-03-02 Tx date 2018-03-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,500
+750,000 vol $0.15 each |
1,382,000 | |
Filed 2017-09-17 Tx date 2017-08-21 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$162,125
+1,013,283 vol $0.16 each |
10,802,249 | |
Filed 2017-09-17 Tx date 2017-08-21 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$198,125
+1,238,283 vol $0.16 each |
||
Filed 2017-08-22 Tx date 2017-08-21 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$198,125
+1,238,283 vol $0.16 each |
11,027,249 | |
Filed 2017-08-10 Tx date 2017-08-09 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$649,350
+4,058,441 vol $0.16 each |
9,788,966 | |
Filed 2017-06-07 Tx date 2017-06-01 |
$Z
Zinc One Resources Inc. (formerly Rockridge Capital Corp.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,011,364 | ||
Filed 2017-06-07 Tx date 2017-06-01 |
$Z
Zinc One Resources Inc. (formerly Rockridge Capital Corp.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
430,525 | ||
Filed 2017-04-26 Tx date 2017-04-24 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-40,500
-450,000 vol $0.09 each |
0 | |
Filed 2017-04-26 Tx date 2017-04-24 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$40,500
+450,000 vol $0.09 each |
1,050,000 | |
Filed 2017-03-29 Tx date 2017-03-28 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$1,964,229
+5,612,083 vol $0.35 each |
||
Filed 2017-03-29 Tx date 2017-03-28 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$1,964,229
+5,612,083 vol $0.35 each |
||
Filed 2017-03-29 Tx date 2017-03-28 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$982,114
+2,806,041 vol $0.35 each |
2,806,041 | |
Filed 2017-03-28 Tx date 2017-01-18 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,307
+57,292 vol $0.145 each |
57,292 | |
Filed 2017-03-28 Tx date 2017-01-18 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,957
+27,292 vol $0.145 each |
||
Filed 2017-03-28 Tx date 2016-11-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-03-28 Tx date 2017-03-28 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$1,964,229
+5,612,083 vol $0.35 each |
5,612,083 | |
Filed 2017-03-28 Tx date 2017-03-28 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,346,899
+5,612,083 vol $0.24 each |
5,730,525 | |
Filed 2017-03-01 Tx date 2017-01-18 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,957
+27,292 vol $0.145 each |
27,292 | |
Filed 2017-03-01 Tx date 2017-01-20 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,672
+11,150 vol $0.15 each |
38,442 | |
Filed 2017-03-01 Tx date 2017-02-23 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+50,000 vol $0.14 each |
88,442 | |
Filed 2017-03-01 Tx date 2016-11-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-12-08 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$27,000
+450,000 vol $0.06 each |
450,000 | |
Filed 2016-12-12 Tx date 2016-07-28 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-07-28 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-12-08 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$9,000
+150,000 vol $0.06 each |
600,000 | |
Filed 2016-12-12 Tx date 2016-07-28 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-07-28 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-07-28 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-12 Tx date 2016-12-08 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$40,500
+450,000 vol $0.09 each |
450,000 | |
Filed 2016-12-12 Tx date 2016-12-08 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$9,999
+166,666 vol $0.06 each |
||
Filed 2016-12-12 Tx date 2016-12-08 |
$VEM
Forrester Metals Inc. (formerly Vena Resources Inc.) |
Williams, William Conard
4 - Director of Issuer
Holder: Williams Videla Family Trust dated February 10, 2014 (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,000
+150,000 vol $0.06 each |
||
Filed 2016-11-03 Tx date 2016-11-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
632,000 | ||
Filed 2016-08-12 Tx date 2016-07-28 |
$VEM
Vena Resources Inc. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-08-12 Tx date 2016-08-10 |
$VEM
Vena Resources Inc. |
Williams, William Conard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+750,000 vol $0.08 each |
750,000 |